Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.415.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.415.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.415.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.243.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.243.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.243.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.98NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.98NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.98NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.566NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.566NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.566NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.480NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.480NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.480NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.579NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.579NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.579NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.10NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N.10NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.10NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
P.1.11 (Gamma)NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
P.1.11 (Gamma)NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
P.1.11 (Gamma)NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.435NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.435NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.435NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.445NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.445NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.445NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.124NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.124NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.124NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.384NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.384NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.384NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
XAQNUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
XAQNYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
XAQNChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
BA.2.3.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
BA.2.3.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
BA.2.3.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.569NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.569NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.569NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.524NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.524NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.524NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
A.23NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
A.23NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used